KURA ONCOLOGY, INC. Accounts Payable and Accrued Liabilities, Current
KURA ONCOLOGY, INC. (KURA) had Accounts Payable and Accrued Liabilities, Current of $66.79 million as of 2025-09-30, per its 10-Q filed 2025-11-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2025-11-04
- 2025-09-30: Accounts Payable and Accrued Liabilities, Current $66.79M.
- 2025-06-30: Accounts Payable and Accrued Liabilities, Current $52.93M.
- 2025-03-31: Accounts Payable and Accrued Liabilities, Current $45.09M.
- 2024-12-31: Accounts Payable and Accrued Liabilities, Current $49.95M.
| Period end | Accounts Payable and Accrued Liabilities, Current | Accounts Payable and Accrued Liabilities, Current as first filed |
|---|---|---|
| 2025-09-30 | $66.79M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $52.93M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $45.09M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $49.95M 10-Q · filed 2025-11-04 | |
| 2024-09-30 | $36.97M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $31.14M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $30.90M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $33.76M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $25.84M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $21.55M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $16.90M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $21.74M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $22.44M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $15.58M 10-Q · filed 2022-08-03 | |
| 2021-12-31 | $20.19M 10-K · filed 2023-02-23 | $22.45M 10-K · filed 2022-02-24 |
| 2021-09-30 | $21.93M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $21.29M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $22.14M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $23.02M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $19.20M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $16.80M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $13.55M 10-Q · filed 2020-05-04 | |
| 2019-12-31 | $15.31M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $12.87M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $10.88M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $11.78M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $13.62M 10-K · filed 2020-02-25 | $13.38M 10-K · filed 2019-03-05 |
| 2018-09-30 | $9.82M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $9.33M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $8.72M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $8.28M 10-K · filed 2019-03-05 | |
| 2017-09-30 | $6.20M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $4.18M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $3.69M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $4.68M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $4.18M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $3.33M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $3.12M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $4.12M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $3.65M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $2.49M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $4.47M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $846.00K 10-K · filed 2016-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |